Synthesis and Mechanism of p53-MDM2 Inhibitors with Heterocyclic Structures: A Focused Review

被引:0
作者
Ji, Li-Tao [1 ]
Zhang, Wenjing [1 ]
Zhang, Yi [1 ]
Zhao, Su [1 ]
Long, Hai-Tao [1 ]
Qin, Li-Qing [1 ]
Tian, Jia-Cheng [1 ]
Li, Hong-Zhang [1 ]
Zhu, Dan-Xue [1 ]
Zhou, Yan [1 ]
Lu, Yi-Duo [1 ]
Wang, Zhen-Chao [1 ,2 ,3 ]
Li, Cheng-Peng [1 ,2 ,3 ]
机构
[1] Guizhou Univ, Coll Pharm, Guiyang 550025, Guizhou, Peoples R China
[2] Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550025, Peoples R China
[3] Guizhou Univ, Guizhou Engn Lab Synthet Drugs, Guiyang 550025, Peoples R China
来源
CHEMISTRYSELECT | 2023年 / 8卷 / 45期
关键词
Small molecule; heterocyclic compounds; p53-MDM2; cancer; synthesis method; SMALL-MOLECULE INHIBITORS; PROTEIN-PROTEIN INTERACTION; STRUCTURE-BASED DESIGN; BIOLOGICAL EVALUATION; MDM2; INHIBITORS; SPIRO-OXINDOLES; CLINICAL-TRIALS; P53; PATHWAY; POTENT; DISCOVERY;
D O I
10.1002/slct.202302240
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
P53 gene mutation is one of the important causes in tumors. p53-MDM2 (murine double minute 2) inhibitors can interrupt p53-dependent gene transcription activity, and inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this article, we focused on the synthesis methods about nutlins and other p53 small molecule inhibitors, in order to find potential new structure for novel p53 small molecule inhibitor synthesizing. Mutation of the p53 gene is among the most important causes of tumors. Inhibitors of p53-MDM2 can impede p53-dependent gene transcription, inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this review we discuss the synthesis of nutlins and other small-molecule p53 inhibitors, with an aim to inspire new structures and methods for the synthesis of future small-molecule p53 inhibitors.+image
引用
收藏
页数:16
相关论文
共 50 条
  • [31] The synthesis and characterization of tetramic acid derivatives as Mdm2-p53 inhibitors
    Muszak, Damian
    Labuzek, Beata
    Brela, Mateusz Z.
    Twarda-Clapa, Aleksandra
    Czub, Miroslawa
    Musielak, Bogdan
    Surmiak, Ewa
    Holak, Tad A.
    JOURNAL OF MOLECULAR STRUCTURE, 2019, 1189 : 161 - 174
  • [32] Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition
    Madden, Michael M.
    Muppidi, Avinash
    Li, Zhenyu
    Li, Xiaolong
    Chen, Jiandong
    Lin, Qing
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1472 - 1475
  • [33] Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
    Bhatia, Neha
    Khator, Rakesh
    Kulkarni, Swanand
    Singh, Yogesh
    Kumar, Pradeep
    Thareja, Suresh
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (32) : 3668 - 3701
  • [34] Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
    Zhu, Haohao
    Gao, Hui
    Ji, Yingying
    Zhou, Qin
    Du, Zhiqiang
    Tian, Lin
    Jiang, Ying
    Yao, Kun
    Zhou, Zhenhe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [35] Insight on Heterocycles as p53-MDM2 Protein-Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation
    Basha, N. Jeelan
    Mohan, R. M.
    CHEMISTRYSELECT, 2024, 9 (10):
  • [36] Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy
    Gupta, Alpana K.
    Bharadwaj, Mausumi
    Kumar, Anoop
    Mehrotra, Ravi
    TOPICS IN CURRENT CHEMISTRY, 2017, 375 (01)
  • [37] Targeting the p53-MDM2 interaction to treat cancer
    Klein, C
    Vassilev, LT
    BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1415 - 1419
  • [38] The p53-MDM2/MDMX axis - A chemotype perspective
    Khoury, Kareem
    Popowicz, Grzegorz M.
    Holak, Tad A.
    Doemling, Alexander
    MEDCHEMCOMM, 2011, 2 (04) : 246 - 260
  • [39] Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction
    Zhuang, Chunlin
    Miao, Zhenyuan
    Zhu, Lingjian
    Zhang, Yongqiang
    Guo, Zizhao
    Yao, Jianzhong
    Dong, Guoqiang
    Wang, Shengzheng
    Liu, Yang
    Chen, Hai
    Sheng, Chunquan
    Zhang, Wannian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) : 5654 - 5661
  • [40] Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond "Failure to rescue"
    Chukwuemeka, Prosper Obed
    Umar, Haruna Isiyaku
    Iwaloye, Opeyemi
    Oretade, Oluwaseyi Matthew
    Olowosoke, Christopher Busayo
    Elabiyi, Michael Omoniyi
    Igbe, Festus Omotere
    Oretade, Oyeyemi Janet
    Eigbe, Joy Oseme
    Adeojo, Funmilayo Janet
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (19) : 9158 - 9176